Christopher M. Smith - 15 Aug 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Executive Officer
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 15 Aug 2022
Transactions value $: $0
Form type: 4
Filing time: 17 Aug 2022, 19:13:39
Previous filing: 27 Jun 2022
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Award	$0	+337K		$0.00	337K	15 Aug 2022	Direct	F1
transaction	NEO	Common Stock	Award	$0	+265K	+78.82%	$0.00	602K	15 Aug 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Stock Option (Right to Buy)	Award	$0	+694K		$0.00	694K	15 Aug 2022	Common Stock	694K	$12.62	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 15, 2022, Mr. Smith was granted 336,767 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2	On August 15, 2022, Mr. Smith was granted 265,452 restricted stock awards. These awards vest on the fourth anniversary date of the grant date.
F3	On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.